| Year |
Citation |
Score |
| 2015 |
Stitelman DH, Brazelton TR, Endo M, Bora A, Traas J, Zoltick PW, Flake AW. Life-Long Transgene Expression in Skeletal Muscle Without Transduction of Satellite Cells Following Embryonic Myogenic Progenitor Transduction by Lentivirus Administered in Utero. Stem Cells and Development. PMID 25915576 DOI: 10.1089/Scd.2014.0585 |
0.34 |
|
| 2005 |
Brazelton TR, Blau HM. Optimizing techniques for tracking transplanted stem cells in vivo. Stem Cells (Dayton, Ohio). 23: 1251-65. PMID 16109764 DOI: 10.1634/Stemcells.2005-0149 |
0.576 |
|
| 2004 |
Briffa NP, Shorthouse R, Chan J, Silva H, Billingham M, Brazelton T, Morris RE. Histological and immunological characteristics of, and the effect of immunosuppressive treatment on, xenograft vasculopathy. Xenotransplantation. 11: 149-59. PMID 14962277 DOI: 10.1046/J.1399-3089.2003.00099.X |
0.329 |
|
| 2003 |
Corbel SY, Lee A, Yi L, Duenas J, Brazelton TR, Blau HM, Rossi FM. Contribution of hematopoietic stem cells to skeletal muscle. Nature Medicine. 9: 1528-32. PMID 14625543 DOI: 10.1038/Nm959 |
0.598 |
|
| 2003 |
Brazelton TR, Nystrom M, Blau HM. Significant differences among skeletal muscles in the incorporation of bone marrow-derived cells. Developmental Biology. 262: 64-74. PMID 14512018 DOI: 10.1016/S0012-1606(03)00357-9 |
0.607 |
|
| 2003 |
Springer ML, Ozawa CR, Banfi A, Kraft PE, Ip TK, Brazelton TR, Blau HM. Localized arteriole formation directly adjacent to the site of VEGF-induced angiogenesis in muscle. Molecular Therapy : the Journal of the American Society of Gene Therapy. 7: 441-9. PMID 12727106 DOI: 10.1016/S1525-0016(03)00010-8 |
0.553 |
|
| 2003 |
Weimann JM, Charlton CA, Brazelton TR, Hackman RC, Blau HM. Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains. Proceedings of the National Academy of Sciences of the United States of America. 100: 2088-93. PMID 12576546 DOI: 10.1073/Pnas.0337659100 |
0.525 |
|
| 2002 |
Blau H, Brazelton T, Keshet G, Rossi F. Something in the eye of the beholder. Science (New York, N.Y.). 298: 361-2; author reply . PMID 12392027 DOI: 10.1126/Science.298.5592.361C |
0.418 |
|
| 2001 |
Blau HM, Brazelton TR, Weimann JM. The evolving concept of a stem cell: entity or function? Cell. 105: 829-41. PMID 11439179 DOI: 10.1016/S0092-8674(01)00409-3 |
0.439 |
|
| 2001 |
Springer ML, Brazelton TR, Blau HM. Not the usual suspects: the unexpected sources of tissue regeneration. The Journal of Clinical Investigation. 107: 1355-6. PMID 11390416 DOI: 10.1172/Jci13248 |
0.584 |
|
| 2000 |
Brazelton TR, Rossi FM, Keshet GI, Blau HM. From marrow to brain: expression of neuronal phenotypes in adult mice. Science (New York, N.Y.). 290: 1775-9. PMID 11099418 DOI: 10.1126/Science.290.5497.1775 |
0.528 |
|
| 2000 |
Adams BF, Berry GJ, Huang X, Shorthouse R, Brazelton T, Morris RE. Immunosuppressive therapies for the prevention and treatment of obliterative airway disease in heterotopic rat trachea allografts. Transplantation. 69: 2260-6. PMID 10868623 DOI: 10.1097/00007890-200006150-00007 |
0.313 |
|
| 2000 |
Adams BF, Brazelton T, Berry GJ, Morris RE. The role of respiratory epithelium in a rat model of obliterative airway disease. Transplantation. 69: 661-4. PMID 10708126 DOI: 10.1097/00007890-200002270-00031 |
0.307 |
|
| 1999 |
Brazelton TR, Adams B, Shorthouse R, Morris RE. Chronic rejection: The result of uncontrolled remodelling of graft tissue by recipient mesenchymal cells? Data from two rodent models and the effects of immunosupressive therapies Inflammation Research. 48. PMID 10667851 DOI: 10.1007/S000110050554 |
0.319 |
|
| 1998 |
Dingemanse SA, Wong R, Dou L, Smith T, Newmark R, Doyle R, Brázelton T, Altinger J, Poirier C, Morris R. First Pharmacokinetic Study With Sdz Rad In Stable Lung Transplant Recipients Transplantation. 65: 264. DOI: 10.1097/00007890-199805131-00739 |
0.304 |
|
| 1998 |
Ikonen T, Briffa N, Brazelton T, Shorthouse R, Berry G, Morris RE. Prevention of Obliterative Airway Disease (OAD) without Immunosuppression in Heterotopic Rat Tracheal Allografts: Anastomosis of Recipient Trachea to Donor Trachea Enables Re-epithelialization of Allografts by Recipient Epithelium Transplantation. 65: 113. DOI: 10.1097/00007890-199805131-00140 |
0.315 |
|
| 1998 |
Brazelton TR, Shorthouse R, Gregory CR, Huang X, Morris RE. RECIPIENT MESENCHYMAL CELLS INFILTRATE AND REMODEL MEDIAL AND ADVENTITIAL TISSUE IN THE RAT FEMORAL ARTERY ALLOGRAFT MODEL OF CHRONIC VASCULAR REJECTION Transplantation. 65: 113. DOI: 10.1097/00007890-199805131-00139 |
0.341 |
|
| 1997 |
Brazelton TR, Shorthouse R, Huang X, Morris RE. Infiltrating recipient mesenchymal cells from the obliterative airway disease lesion and dramatically remodel graft tissue in a model of chronic lung rejection Transplantation Proceedings. 29: 2614. PMID 9290763 DOI: 10.1016/S0041-1345(97)00529-0 |
0.365 |
|
| 1997 |
Brazelton TR, Adams BA, Cheung AC, Morris RE. Progression of obliterative airway disease occurs despite the removal of immune reactivity by retransplantation Transplantation Proceedings. 29: 2613. PMID 9290762 DOI: 10.1016/S0041-1345(97)00528-9 |
0.315 |
|
| 1997 |
Reichenspurner H, Soni V, Nitschke M, Berry GJ, Brazelton TR, Shorthouse R, Huang X, Reitz BA, Morris RE. Obliterative airway disease after heterotopic tracheal xenotransplantation: Pathogenesis and prevention using new immunosuppressive agents Transplantation. 64: 373-383. PMID 9275099 DOI: 10.1097/00007890-199708150-00001 |
0.316 |
|
| Show low-probability matches. |